University of Texas-Health Science Center at Houston: Imaging Reveals New Results From Landmark Stem Cell Trial for Stroke
September 20, 2019
September 20, 2019
HOUSTON, Texas, Sept. 20 [TNSmedicalresearch] -- The University of Texas Health Science Center at Houston issued the following news release:
Researchers led by Sean I. Savitz, MD, reported today in the journal Stem Cells that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.
In addition, using serial diffusion tensor imaging, . . .
Researchers led by Sean I. Savitz, MD, reported today in the journal Stem Cells that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.
In addition, using serial diffusion tensor imaging, . . .